BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8757020)

  • 1. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.
    Meltzer CC; Zubieta JK; Brandt J; Tune LE; Mayberg HS; Frost JJ
    Neurology; 1996 Aug; 47(2):454-61. PubMed ID: 8757020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.
    Ibáñez V; Pietrini P; Alexander GE; Furey ML; Teichberg D; Rajapakse JC; Rapoport SI; Schapiro MB; Horwitz B
    Neurology; 1998 Jun; 50(6):1585-93. PubMed ID: 9633698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter.
    DeCarli C; Grady CL; Clark CM; Katz DA; Brady DR; Murphy DG; Haxby JV; Salerno JA; Gillette JA; Gonzalez-Aviles A; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1996 Feb; 60(2):158-67. PubMed ID: 8708645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.
    Labbé C; Froment JC; Kennedy A; Ashburner J; Cinotti L
    Alzheimer Dis Assoc Disord; 1996; 10(3):141-70. PubMed ID: 8876777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease.
    Bokde AL; Pietrini P; Ibáñez V; Furey ML; Alexander GE; Graff-Radford NR; Rapoport SI; Schapiro MB; Horwitz B
    Arch Neurol; 2001 Mar; 58(3):480-6. PubMed ID: 11255453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease.
    Chételat G; Desgranges B; Landeau B; Mézenge F; Poline JB; de la Sayette V; Viader F; Eustache F; Baron JC
    Brain; 2008 Jan; 131(Pt 1):60-71. PubMed ID: 18063588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
    Haense C; Buerger K; Kalbe E; Drzezga A; Teipel SJ; Markiewicz P; Herholz K; Heiss WD; Hampel H
    Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
    Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A
    Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
    J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK; Harwood DG; Melrose RJ; Mandelkern MA; Campa OM; Walston A; Sultzer DL
    Int J Geriatr Psychiatry; 2010 Nov; 25(11):1150-8. PubMed ID: 20069587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined effects of microglia activation and brain glucose hypometabolism in early-onset Alzheimer's disease.
    Tondo G; Iaccarino L; Caminiti SP; Presotto L; Santangelo R; Iannaccone S; Magnani G; Perani D
    Alzheimers Res Ther; 2020 Apr; 12(1):50. PubMed ID: 32354345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping cerebral atrophy and hypometabolism on
    Siti Aishah AA; Normala I; Faruque Reza M; M Iqbal S
    Med J Malaysia; 2023 Jan; 78(1):46-53. PubMed ID: 36715191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Amyloid Angiopathy-Related Microbleeds Correlate with Glucose Metabolism and Brain Volume in Alzheimer's Disease.
    Samuraki M; Matsunari I; Yoshita M; Shima K; Noguchi-Shinohara M; Hamaguchi T; Ono K; Yamada M
    J Alzheimers Dis; 2015; 48(2):517-28. PubMed ID: 26402015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
    Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
    J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.